Tina-Quant Hemoglobin A1C GEN.2 Test System
Assay, Glycosylated Hemoglobin. 510(k) K072714, from Roche Diagnostics Corp. (Indianapolis, IN). Product code LCP, class 2.
As of Nov 19, 2026, K072714 is an FDA 510(k) held by Roche Diagnostics Corp., substantially equivalent on Apr 18, 2008 after 206 days, with 1 recall tied to it in FDA's recall database.
- Review time: 206 days
- Recalls: 1
- Cited as a predicate by: 2 devices
evice Name: Tina-Quant® Hemoglobin A1c Gen.2 Test System Indication For Use: For the quantitative determination of percent hemoglobin A1c in whole blood (or hemolysate derived from whole blood) on Roche clinical chemistry analyzers. HbA1c determinations are useful for monitoring of long-term blood glucose control in individuals with diabetes mellitus.
- Tina-Quant Hemoglobin A1C GEN.2 TestK052464 · Roche Diagnostics Corp. · Sep 30, 2005
- Tina-Quant HBA1C GEN.2K110313 · Roche Diagnostics · Dec 23, 2011
- TQ HBA1C GEN3K102914 · Roche · Jan 20, 2011
| Started | Recall | Status |
|---|---|---|
| Oct 4, 2016 | Z-0395-2017Roche Diagnostics has confirmed elevated QC and patient sample recovery for individual Tina-quant Hemoglobin A1c Gen.2 and Tina-quant Hemoglobin A1cDx Gen.2 cassettes/bottles. This issue occurred over multiple lots.… | Terminated |
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Sep 25, 2007
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files